These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4569055)

  • 1. Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229).
    Haskell CM; Canellos GP; Cooney DA; Hardesty CT
    Cancer Chemother Rep; 1972 Oct; 56(5):611-4. PubMed ID: 4569055
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo effects of intraperitoneally injected L-asparaginase solution and L-asparaginase immobilized within semipermeable nylon microcapsules with emphasis on blood L-asparaginase, 'body' L-asparaginase, and plasma L-asparagine levels.
    Siu Chong ED; Chang TM
    Enzyme; 1974; 18(3):218-39. PubMed ID: 4601662
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and pharmacological studies with asparaginase in man.
    Ohnuma T; Holland JF; Freeman A; Sinks LF
    Cancer Res; 1970 Sep; 30(9):2297-305. PubMed ID: 4920133
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of canine serum asparagine levels by L -asparaginase immobilized on collagen: a potential form of cancer chemotherapy.
    Olanoff LS; Bernath FR; Venkatasubramanian K; Joyeuse R
    Trans Am Soc Artif Intern Organs; 1975; 21():156-64. PubMed ID: 807012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocmical and pharmacologic effects of L-asparaginase in man.
    Haskell CM; Canellos GP; Cooney DA; Hansen HH
    J Lab Clin Med; 1970 May; 75(5):763-70. PubMed ID: 4909251
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of immunization to L-asparaginase on antitumor and enzymatic activity.
    Goldberg AI; Cooney DA; Glynn JP; Homan ER; Gaston MR; Milman HA
    Cancer Res; 1973 Feb; 33(2):256-61. PubMed ID: 4569788
    [No Abstract]   [Full Text] [Related]  

  • 7. L-asparaginase activity in plasma and other biological fluids.
    Schwartz MK; Lash ED; Oettgen HF; Tomato FA
    Cancer; 1970 Feb; 25(2):244-52. PubMed ID: 4905152
    [No Abstract]   [Full Text] [Related]  

  • 8. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.
    Nath CE; Dallapozza L; Eslick AE; Misra A; Carr D; Earl JW
    Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nutritional requirement of cancer cells: inhibition of the growth of cancer cells by L-asparaginase].
    Honjo T; Hayaishi O
    Tanpakushitsu Kakusan Koso; 1970 Apr; 15(5):515-23. PubMed ID: 4913828
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.
    Broome JD
    Br J Cancer; 1968 Sep; 22(3):595-602. PubMed ID: 4878639
    [No Abstract]   [Full Text] [Related]  

  • 11. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
    Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy.
    Miller HK; Salser JS; Balis ME
    Cancer Res; 1969 Jan; 29(1):183-7. PubMed ID: 5763976
    [No Abstract]   [Full Text] [Related]  

  • 13. Basis for loss of therapeutic effectiveness of L-asparaginase in sensitized mice.
    Baechtel S; Prager MD
    Cancer Res; 1973 Aug; 33(8):1966-9. PubMed ID: 4578567
    [No Abstract]   [Full Text] [Related]  

  • 14. L-asparaginase: a review.
    Wriston JC; Yellin TO
    Adv Enzymol Relat Areas Mol Biol; 1973; 39():185-248. PubMed ID: 4583638
    [No Abstract]   [Full Text] [Related]  

  • 15. Asparaginase and leukaemia.
    Lancet; 1968 May; 1(7551):1075-6. PubMed ID: 4172470
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of the transferase activity of L-asparaginase].
    Buka MR; Zhagat RA; Kirstukas IP; Chepuka LY
    Vopr Med Khim; 1975; 21(5):548-52. PubMed ID: 3024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and pharmacologic properties of L-asparaginase bonded to dacron vascular prostheses.
    Cooney DA; Weetall HH; Long E
    Biochem Pharmacol; 1975 Feb; 24(4):503-15. PubMed ID: 234240
    [No Abstract]   [Full Text] [Related]  

  • 18. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
    Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG
    Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and mechanism of clearance of L-asparaginase (NSC-109229).
    Ho DH; Carter CJ; Thetford B; Frei E
    Cancer Chemother Rep; 1971 Dec; 55(5):539-45. PubMed ID: 4946079
    [No Abstract]   [Full Text] [Related]  

  • 20. Gel entrapped L-asparaginase: kinetic behavior and antitumor activity.
    O'Driscoll KF; Korus RA; Ohnuma T; Walczack IM
    J Pharmacol Exp Ther; 1975 Nov; 195(2):382-8. PubMed ID: 241845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.